FiledIssuerIndustrySold
Sept 2024Harbinger Motors Inc.Other Technology$73M
Jul 2024Naveris, Inc.Biotechnology$17M
Feb 2024Adverum Biotechnologies, Inc.Biotechnology$128M
Dec 2023Spyre Therapeutics, Inc.Biotechnology$180M
Oct 2023Harpoon Therapeutics, Inc.Biotechnology$100M
Sept 2023MAPS Public Benefit CorpPharmaceuticals$215M
Jul 2023Aeglea BioTherapeutics, Inc.Biotechnology$210M
Jan 2023Augmented Reality Concepts, Inc.Other Technology$104M
Jul 2022Annexon, Inc.Biotechnology$130M
Jun 2022Invoca, Inc.Other$83M
May 2022PolySign, Inc.Agents: n/aOther Technology$50M
Apr 2022RightHand Robotics, Inc.Other Technology$25M
Apr 2022MedAvail Holdings, Inc.Pharmaceuticals$40M
Nov 2021PierianDx, Inc.Agents: Cowen and Company, LLCBiotechnology$17M
Oct 2021Gritstone bio, Inc.Biotechnology$55M
Oct 2021RightHand Robotics, Inc.Other Technology$19M
Sept 2021Aadi Bioscience, Inc.Agents: Cowen and Company LLCBiotechnology$155M
Feb 2021Orchard Therapeutics plcBiotechnology$150M
Feb 2021DarioHealth Corp.Biotechnology$70M
Jan 2021Kempharm, IncPharmaceuticals$31M
Dec 2020Alphatec Holdings, Inc.Other Health Care$30M
Nov 2020MedAvail, Inc.Other Health Care$97M
Oct 2020Olema Pharmaceuticals, Inc.Agents: OM Co-Investment LLCPharmaceuticals$87M
Aug 2020Alpine Immune Sciences, Inc.Biotechnology$60M
Jul 2020Frequency Therapeutics, Inc.Biotechnology$42M
Jun 2020Amyris, Inc.Manufacturing$200M
Jun 2020Hawk Acquisitions LLC / FlAgents: .Restaurants$24M
Mar 2020DermTech, Inc.Other Health Care$65M
Dec 2019Kempharm, IncPharmaceuticals$71M
Nov 2019Applied Therapeutics Inc.Agents: N/ABiotechnology$20M
Sept 2019Zeno Pharma, LLCPharmaceuticals-
Aug 2019Stereotaxis, Inc.Agents: Cowen and Company LLCOther Technology$25M
Aug 2019Botanix Pharmaceuticals Ltd.Pharmaceuticals$20M
Jul 2019Neptune Wellness Solutions Inc.Other$37M
May 2019Sundial Growers Inc.Other$41M
May 2019Northern Swan Holdings, Inc.Agents: COWEN AND COMPANY, LLCOther$58M
Jan 2019Cabaletta Bio, Inc.Biotechnology$50M
Jan 2019Greenlane Holdings, LLCOther$48M
Sept 2018Atreca, Inc.Biotechnology$125M
Dec 2017Trillium Therapeutics Inc.Pharmaceuticals$20M
From the SEC's Form D data sets: the issuer named this firm as paid to sell the offering. The latest 40 shown.